FDA 510(k) · Oxehealth
K211906: Vital Signs (Oxehealth Limited)
Oxehealth Limited received FDA 510(k) K211906 for Vital Signs, with a decision date of Jul 20, 2021 (substantially equivalent).
Prescription or OTC: Unknown (no FDA document we parsed states it).
FDA facts
| FDA number | K211906 |
|---|---|
| Pathway | 510(k) |
| Applicant | Oxehealth Limited |
| Device name | Vital Signs |
| Product code | QME: Software For Optical Camera-Based Measurement Of Pulse Rate, Heart Rate, Breathing Rate, And/Or Respiratory Rate |
| Regulation (21 CFR) | 870.2785 |
| Device class | Class 2 |
| Date received | Jun 21, 2021 |
| Decision date | Jul 20, 2021 |
| Decision | Substantially Equivalent (SESE) |
| 510(k) type | Special |
Source: openFDA device 510(k) data, data through Oct 26, 2026.
Indications for use parsed from FDA documents
The Oxehealth Vital Signs device is intended for noninvasive spot measurement of pulse rate and estimated breathing rate (chest wall movements) when the subject is still. It is software assessing video footage from a fixed-installation solution for use within single occupancy rooms within hospitals, general care and secured environments with professional healthcare oversight and where a framework exists which mandates periodic checks by a trained professional to ensure subject safety. The Oxehealth system is intended for use by appropriately trained staff with a duty of care, and should not be used by untrained users. The Oxehealth Vital Signs device is indicated for use on humans 18 years of age or older who do not require critical care or continuous vital signs monitoring. The device is not intended to be the sole method of checking the physical health of a subject.
Extracted automatically from FDA's 510(k) summary. It can contain extraction errors and is not a verified quote. Read the wording in the FDA PDF before relying on it.
Predicates parsed from FDA documents
No predicate numbers were parsed for this record. The FDA summary, if available, names the predicate.
Later records that cite K211906
- K254169 SmartSpectra Vital Signs Monitor 1.0 (Presage, Jun 18, 2026, QME)
- K260066 PanopticAI Vital Signs (1.6.1-22) (PanopticAI, May 21, 2026, QME)
- K251200 Vital Signs (Oxehealth, Feb 2, 2026, QME)
- K243687 Vital Signs (Oxehealth, Aug 27, 2025, QME)
- K250078 Informed Vital Core Application (IVC App) (v2.0.0.2.0.0) (Mindset Medical, May 30, 2025, QME)
- K240890 PanopticAI Vital Signs (PanopticAI, Dec 23, 2024, QME)
- K241633 Informed Vital Core Application (IVC App) (Mindset Medical, Nov 18, 2024, QME)
- K223622 FaceHeart Vitals Software Development Kit (FH vitals SDK) (FaceHeart, Sep 1, 2023, QME)
- K220899 Oxehealth Vital Signs (Oxehealth, Apr 29, 2022, QME)
ChatPPG interpretation
A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.
Product code QME is "Software For Optical Camera-Based Measurement Of Pulse Rate, Heart Rate, Breathing Rate, And/Or Respiratory Rate", class 2, 21 CFR 870.2785. FDA's definition: "The device uses software algorithms to analyze video signal and estimate pulse rate, heart rate, respiratory rate and/or breathing rates. This device is not intended to independently direct therapy."
Our labels for filtering: claim Heart rate / pulse, sensor Camera (rPPG). These are heuristics, not FDA fields.